(Q83940474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Thomas Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Wilfried Kuhn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

22 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

447-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758261%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-006-0132-0

29 January 2020

exact match

0 references

cites work

The effect of entacapone on homocysteine levels in Parkinson disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0132-0

Detection of tolcapone in the cerebrospinal fluid of parkinsonian subjects

21 January 2018

1 reference

12 December 2020

Nigral endothelial dysfunction, homocysteine, and Parkinson's disease

1 reference

12 December 2020

Effects of homocysteine on the dopaminergic system and behavior in rodents

1 reference

12 December 2020

Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration

1 reference

12 December 2020

Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

1 reference

12 December 2020

Benefit of folic acid supplementation in parkinsonian patients treated with levodopa

1 reference

12 December 2020

Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons

1 reference

12 December 2020

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications

1 reference

12 December 2020

Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease

1 reference

12 December 2020

Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats

1 reference

12 December 2020

N-methylation underlying Parkinson's disease.

1 reference

12 December 2020

Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype

1 reference

12 December 2020

Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease

1 reference

12 December 2020

18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease

1 reference

12 December 2020

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

1 reference

12 December 2020

Switch-over from tolcapone to entacapone in severe Parkinson's disease patients

1 reference

12 December 2020

Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.

1 reference

12 December 2020